Published in J Cancer Res Clin Oncol on October 09, 2007
The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle. J Virol (2009) 0.85
Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients. Oncologist (2013) 0.83
Malignancy in the HIV-infected patients undergoing liver and kidney transplantation. Curr Opin Oncol (2012) 0.78
Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men. PLoS One (2013) 0.77
Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis. BMC Cancer (2014) 0.77
Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet (1995) 10.63
Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med (2005) 7.83
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med (2002) 7.06
Kaposi's sarcoma. N Engl J Med (2000) 6.81
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05
p53 inhibition by the LANA protein of KSHV protects against cell death. Nature (2000) 4.74
Risk of neoplasia in renal transplant patients. Lancet (1995) 2.65
Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med (1998) 2.52
Kaposi's sarcoma: a clinicopathologic study with particular reference to its relationship to the reticuloendothelial system. Medicine (Baltimore) (1965) 2.04
Cancers complicating organ transplantation. N Engl J Med (1990) 1.57
Retracted Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc Natl Acad Sci U S A (1999) 1.52
The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes. Am J Pathol (1989) 1.21
Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol (1999) 1.09
Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant (2006) 1.03
Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect (2001) 1.00
Liver and intestine transplantation in the United States, 1995-2004. Am J Transplant (2006) 0.99
Sarcomas in organ allograft recipients. Transplantation (1995) 0.98
Treatment of Kaposi's sarcoma after solid organ transplantation. J Clin Oncol (1997) 0.90
Kaposi's sarcoma in renal transplant recipients. Experience at Johannesburg Hospital, 1966-1989. S Afr Med J (1994) 0.82
Risk for Kaposi's sarcoma among Italian women with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.81
Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines. Int J Oncol (1999) 0.80
Kaposi's sarcoma in renal-transplant recipients: experience at the Catholic University in Rome, 1988-1996. Dermatology (1997) 0.79
Kaposi's sarcoma in liver transplant recipients: morphological and clinical description. Liver Transpl (2001) 0.79
Treatment of Kaposi's sarcoma with vinblastine. Cancer (1980) 0.77
Kaposi sarcoma in solid organ transplant recipients: a single center report. Transplant Proc (2005) 0.77
Kaposi's sarcoma after renal transplantation. N Engl J Med (2005) 0.75
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med (2013) 5.72
Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med (2014) 3.08
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med (2003) 2.61
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry. Clin Infect Dis (2012) 2.34
Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl (2002) 2.18
Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia. J Clin Oncol (2014) 2.04
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood (2011) 2.02
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica (2009) 1.99
Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation (2002) 1.95
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials. Blood (2004) 1.91
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Serum markers of hepatocellular carcinoma. Dig Dis Sci (2010) 1.76
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation. Transplantation (2005) 1.59
First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. Transplantation (2010) 1.58
ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl (2006) 1.57
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases. PLoS One (2015) 1.50
Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol (2011) 1.50
Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest (2009) 1.49
Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol (2011) 1.46
Female form of persistent müllerian duct syndrome: MDCT findings. Clin Imaging (2008) 1.45
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. Haematologica (2008) 1.44
Impact of procedure volumes and focused practice on short-term outcomes of elective and urgent colon cancer resection in Italy. PLoS One (2013) 1.43
Acute promyelocytic leukemia in very elderly patients: still a clinical challenge. Leuk Lymphoma (2009) 1.41
Laparoscopic radiofrequency ablation in the caudate lobe for hepatocellular carcinoma before liver transplantation. J Laparoendosc Adv Surg Tech A (2012) 1.40
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood (2005) 1.39
Use of activated protein C in liver transplantation patients with septic shock. Liver Transpl (2008) 1.38
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer. Lung Cancer (2009) 1.30
Intermittent gastric outlet obstruction due to a gallstone migrated through a cholecysto-gastric fistula: a new variant of "Bouveret's syndrome". World J Gastroenterol (2008) 1.30
Pain and emotional distress in leukemia patients at diagnosis. Leuk Res (2009) 1.26
Solid pseudopapillary tumour of the pancreas. Lancet Oncol (2003) 1.24
Impact of biliary complications in right lobe living donor liver transplantation. Transpl Int (2006) 1.23
Robot assistance in liver surgery: a real advantage over a fully laparoscopic approach? Results of a comparative bi-institutional analysis. Int J Med Robot (2013) 1.19
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res (2011) 1.18
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment. Blood (2009) 1.15
Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist (2011) 1.14
Giant gastrointestinal stromal tumor (GIST) of the stomach cause of high bowel obstruction: surgical management. World J Surg Oncol (2013) 1.13
Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding. World J Gastroenterol (2012) 1.12
Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous? J Am Coll Surg (2005) 1.11
Is it better to transfer long-term cancer survivors to general practitioners or develop clinics for long-term survivors within the cancer centers? J Clin Oncol (2013) 1.08
Recurrence of breast cancer in elderly women. J Clin Oncol (2013) 1.08
Serum markers of intrahepatic cholangiocarcinoma. Dis Markers (2013) 1.07
Re: Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg (2015) 1.07
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial. J Clin Oncol (2013) 1.07
Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment. Blood (2002) 1.06
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation (2008) 1.06
Parvoviruses in blood donors and transplant patients, Italy. Emerg Infect Dis (2008) 1.05
Operative Drainage Following Pancreatic Resections: We Need More Evidence. Ann Surg (2015) 1.05
Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years. J Mol Diagn (2011) 1.03
Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer (2003) 1.03
The value of laparoscopic liver surgery for solid benign hepatic tumors. Surg Endosc (2007) 1.03
Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy. Ann Surg Oncol (2015) 1.02
AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies. Curr HIV Res (2009) 1.00
The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation. Haematologica (2013) 1.00
The use of intrathecal morphine for postoperative pain relief after liver resection: a comparison with epidural analgesia. Anesth Analg (2006) 1.00
Cystic peritoneal mesothelioma: report of a case. Surg Today (2010) 0.98
Adenocarcinoid tumor of the extrahepatic biliary tract. Int J Surg Pathol (2008) 0.98
Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study. Transplantation (2011) 0.97
How I treat HHV8/KSHV-related diseases in posttransplant patients. Blood (2012) 0.97
Palliative radiotherapy: run with the hare and hunt with the hounds. J Clin Oncol (2013) 0.96
Increased prothrombin time and platelet counts in living donor right hepatectomy: implications for epidural anesthesia. Liver Transpl (2004) 0.96
Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist (2012) 0.95
Ectopic fat is linked to prior cardiovascular events in men with HIV. J Acquir Immune Defic Syndr (2012) 0.95
Liver metastases from colorectal cancer: present surgical approach. Hepatogastroenterology (2003) 0.95
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood (2007) 0.94
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. World J Gastroenterol (2013) 0.94
Primary squamous cell carcinoma of the liver associated with Caroli's disease: a case report. Onkologie (2011) 0.93